Es Sitting Height Measurement

---
name: es-sitting-height-measurement
description: This skill involves measuring standing and sitting height in childhood cancer survivors with spinal radiation exposure to assess for disproportionate short stature due to spinal foreshortening, including calculation of the upper-to-lower segment ratio. It is triggered by questions such as "How do I assess for spinal radiation impact on growth?" or "Should I measure sitting height in this survivor with chest/pelvis radiation?"
---

# Measure sitting height to evaluate spinal radiation effects

## STEP 1 — Gather Information
Collect standing height (barefoot, stadiometer), sitting height (sitting height stadiometer or table), leg length if needed, sex, age, ethnicity, and radiation history (type, dose, age at exposure). If sitting height cannot be measured, obtain arm span as an estimate.

## STEP 2 — Rule In / Rule Out
Is there a history of radiation that included the spine (TBI, CSI, chest, abdomen, or pelvis)? If yes, proceed; if no, spinal foreshortening assessment via sitting height is not indicated.

## STEP 3 — Classify or Stratify
Calculate lower segment = standing height – sitting height (or leg length). Upper segment = sitting height (or standing height – leg length). Compute upper-to-lower segment ratio and compare to age/sex/ethnicity-specific reference values (or Z‑score). Classify as normal ratio or reduced ratio indicating spinal foreshortening.

## STEP 4 — Decide
If ratio is reduced, document spinal foreshortening, refer for endocrine evaluation (including GHD testing), monitor growth every 6–12 months, and consider GH therapy only if GHD is confirmed. If ratio is normal, reassess short stature for other causes (e.g., GHD, nutrition).

## Clinical Guardrails / Mimics / Pitfalls
Do not rely on sitting height alone if measurement technique is unreliable; avoid using arm span as a substitute unless necessary and interpret with caution. Do not mistake proportionate short stature (e.g., GHD) for spinal foreshortening. Do not initiate GH without confirmed GHD. Remember that reference upper‑to‑lower ratios vary by ethnicity.

## Concrete Clinical Example
A 12‑year‑old survivor of medulloblastoma who received CSI 30 Gy at age 5 presents with standing height 130 cm (−2.5 SD) and sitting height 60 cm. Leg length is 70 cm (standing – sitting). Upper‑to‑lower ratio = 60/70 = 0.86, below the expected ~0.90 for age, indicating spinal foreshortening. Endocrine work‑up reveals GHD; GH therapy is initiated after confirmation.

**Source:** Hypothalamic Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society Clinical Practice Guideline, Sklar et al., 2018, doi:10.1210/jc.2018-01175

> **TODO:** consider adding scripts/calc.py for the es-sitting-height-measurement calculator